Cracking The Code: Understanding Analyst Reviews For Biogen
Cracking The Code: Understanding Analyst Reviews For Biogen
破译密码：理解渤健公司的分析师评论
During the last three months, 20 analysts shared their evaluations of Biogen (NASDAQ:BIIB), revealing diverse outlooks from bullish to bearish.
在过去的三个月里，20名分析师分享了对Biogen（纳斯达克：BIIB）的评估，展示了从看好到看淡的不同展望。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
总结他们最近的评估，下表展示了过去30天内不断变化的情绪，并将其与之前的几个月进行了比较。
Analysts have set 12-month price targets for Biogen, revealing an average target of $281.45, a high estimate of $317.00, and a low estimate of $190.00. This current average represents a 2.31% decrease from the previous average price target of $288.11.
分析师为Biogen设定了12个月的价格目标，揭示了平均目标价281.45美元，高估317.00美元，低估190.00美元的数据。当前平均价格代表了一个2.31％的降幅，以前的平均价格目标为288.11美元。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析师评级：全面解析
An in-depth analysis of recent analyst actions unveils how financial experts perceive Biogen. The following summary...
对最近分析师行动的深入分析揭示了金...
登录免费看全文
登录/注册